Skip to main content

Donald Patrick McDonnell

Glaxo-Wellcome Distinguished Professor of Molecular Cancer Biology, in the School of Medicine
Pharmacology & Cancer Biology
Duke Box 3813, Durham, NC 27710
2138 MSRB3, 3 Genome Ct., Durham, NC 27710

Awards & Honors


St. Patrick's Day Science Medal

Other Science Foundation Ireland (SFI) · 2022

Brinker Award for Scientific Distinction in Basic Science

Other Susan G. Komen · 2020

Gerald D. Aurbach Award for Outstanding Translational Research

Other Endocrine Society · 2020

Fellow (NAI)

Other National Academy of Inventors · 2020 More about this award

Distinguished Faculty Award

Other Duke Medical Alumni Association · 2019

Robert R. Ruffolo Career Achievement Award in Pharmacology

Other ASPET · 2017

Member

National National Academy of Medicine · 2016 More about this award

Distinguished Alumni Award

Other Baylor College of Medicine · 2013

Roy O. Greep Award

Other The Endocrine Society · 2013

AAAS Fellow

National American Association for the Advancement of Science, The · 2011

Honorary Fellow

Other Royal College of Physicians, Ireland · 2007

Medtronic AVE Award for Health Care and Medical Science

Other National University of Ireland, Galway · 2006

MERIT Award

National National Institutes of Health · 2005

Irish American Life Science Award

Other Biolink USA-Ireland · 2005

Award for Experimental Therapeutics

Other Pharmacia-ASPET · 2005

Ernst Oppenheimer Award

Other Endocrine Society · 2003

Glaxo-Wellcome Distinguished Professor of Molecular Cancer Biology

Other Duke University School of Medicine · 2002

SERM Research Award

Other NAMS / Eli LIlly and Company · 2000

John J. Abel Award

Other ASPET · 1999

Robert E. Weitzman Award

Other Endocrine Society · 1997

Irish Young Scientist

Other Aer Lingus · 1978

Phillips European Young Scientist

Other European Union · 1978

In the News


Published April 8, 2025
How Duke Research Turned Failure Into Hope for Patients With Breast Cancer
Published September 9, 2024
Study Solves Testosterone’s Paradoxical Effects in Prostate Cancer
Published February 13, 2023
New Therapy for Advanced Breast Cancer Has Roots in Duke Lab
Published March 17, 2022
Irish PM Honors Cancer Biologist Donald McDonnell With Science Medal
Published October 13, 2021
Link Between Melanoma and Estrogen Could Lead to New Therapeutic Approach
Published August 26, 2021
High Cholesterol Fuels Cancer By Fostering Resistance to a Form of Cell Death
Published October 22, 2019
New Approach to Stopping Breast Cancer Recurrence Shows Promise in Mice
Published June 18, 2019
Inhibiting This Enzyme Unleashes the Immune System on Breast Cancer
Published May 3, 2018
The Campus Lab That Makes and Sells Molecules
Published February 21, 2017
Prostate Cancer Cells Grow with Malfunction of Cholesterol Control in Cells
Published October 15, 2014
Prostate Cancer's Penchant for Copper May Be A Fatal Flaw
Published December 3, 2013
High Cholesterol's Link to Breast Cancer
Published December 2, 2013
Cholesterol 'fuels' breast cancer
Published December 2, 2013
Duke study: Many breast cancers may be linked with cholesterol byproduct
Published December 2, 2013
High Cholesterol Fuels the Growth and Spread of Breast Cancer
Published August 1, 2013
Komen grants $3.6 million to Duke, UNC breast cancer research
Published June 28, 2013
Osteoporosis drug blocks growth of breast cancer cells
Published June 18, 2013
Osteoporosis Drug Stops Growth of Breast Cancer Cells, Even in Resistant Tumors
Published June 17, 2013
Brittle bone drug can fight off breast cancer